SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-22-011602
Filing Date
2022-04-29
Accepted
2022-04-29 16:47:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 15517
2 proxy_001.jpg GRAPHIC 332806
3 proxy_002.jpg GRAPHIC 216734
  Complete submission text file 0001493152-22-011602.txt   773306
Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40544 | Film No.: 22876611
SIC: 2834 Pharmaceutical Preparations